Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-18-051693)

Filing Details

Accession Number:
0001209191-18-051693
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-19 18:41:10
Reporting Period:
2018-09-17
Accepted Time:
2018-09-19 18:41:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1294133 Inogen Inc INGN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1596087 Matt Scribner C/O Inogen, Inc.
326 Bollay Drive
Goleta CA 93117		 No No No Yes
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-17 2,000 $0.81 7,595 No 4 M Direct
Common Stock Disposition 2018-09-17 386 $275.78 7,209 No 4 S Direct
Common Stock Disposition 2018-09-17 200 $276.62 7,009 No 4 S Direct
Common Stock Disposition 2018-09-17 100 $277.49 6,909 No 4 S Direct
Common Stock Disposition 2018-09-17 100 $280.04 6,809 No 4 S Direct
Common Stock Disposition 2018-09-17 600 $283.17 6,209 No 4 S Direct
Common Stock Disposition 2018-09-17 500 $284.89 5,709 No 4 S Direct
Common Stock Disposition 2018-09-17 114 $285.81 5,595 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-09-17 2,000 $0.00 2,000 $0.81
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,683 2022-03-28 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2018.
  2. Represents the weighted average share price of an aggregate total of 386 shares sold in the price range of $275.22 to $276.20 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $276.45 to $276.78 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Represents the weighted average share price of an aggregate total of 600 shares sold in the price range of $282.92 to $283.75 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $284.48 to $285.34 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. Represents the weighted average share price of an aggregate total of 114 shares sold in the price range of $285.80 to $285.90 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012.